Use of whole exome sequencing in the NICU: Case of an extremely low birth weight infant with syndromic features

Mol Cell Probes. 2019 Jun:45:89-93. doi: 10.1016/j.mcp.2019.03.002. Epub 2019 Mar 15.

Abstract

Single gene (Mendelian) disorders are one of the leading causes of neonatal morbidity and mortality. However, in the setting of preterm birth phenotypic features of genetic diseases are often undifferentiated and are clinically very difficult to interpret based on the wide range of differential diagnoses. We report an extremely low birth weight infant (ELBW) born prematurely at 23 + 0 gestational weeks after twin pregnancy with a novel clinical manifestation with persistent hyperglycaemia as well as the known manifestations of disease-associated hypokinesia, renal salt wasting, and multifocal atrial tachycardia. The patient died of heart failure on the 72nd day of life. Whole exome sequencing (WES) revealed a previously well established, disease-causing heterozygous likely pathogenic variant in the Harvey rat sarcoma viral oncogene homolog (HRAS)-gene (c.35G > C, p. G12A, rs104894230), which implied the clinical diagnosis of Costello syndrome (CS; OMIM#190020.0004). The twin brother merely had complications related to preterm birth and did not show any CS symptoms. In conclusion, our case illustrated that CS should be considered in ELBW infants showing a life-threatening combination of complex cardiac arrhythmia and hypokinesia. If a syndromic disorder is suspected in the neonatal intensive care unit (NICU) setting, rapid WES is a useful, non-invasive diagnostic tool in critically ill ELBW infants.

Keywords: Arrhythmia; Costello syndrome; Extremely low birth weight infant; HRAS; Neonatal exome; whole exome sequencing.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Exome Sequencing / methods*
  • Fatal Outcome
  • Female
  • Humans
  • Infant, Extremely Low Birth Weight / blood
  • Infant, Newborn
  • Infant, Premature / blood
  • Intensive Care Units, Neonatal
  • Male
  • Polymorphism, Single Nucleotide
  • Pregnancy
  • Pregnancy, Twin / genetics*
  • Proto-Oncogene Proteins p21(ras) / genetics*

Substances

  • HRAS protein, human
  • Proto-Oncogene Proteins p21(ras)